Dr Bais Surgical And Medical Institute Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.00 Cr
- Company Age 30 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.25 Cr
- Revenue Growth 0.39%
- Profit Growth 580.36%
- Ebitda 439.12%
- Net Worth 12.45%
- Total Assets 1.44%
About Dr Bais Surgical And Medical Institute
Dr Bais Surgical And Medical Institute Private Limited (DBSAMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 November 1994 and has a history of 30 years and three months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.00 Cr.
The company currently has active open charges totaling ₹1.25 Cr.
Smita Kelkar, Vaibhav Kelkar, and Ulhas Kelkar serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110MH1994PTC082917
- Company No.
082917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 1994
- Date of AGM
05 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Dr Bais Surgical And Medical Institute?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ulhas Kelkar  | Director | 14-Nov-1994 | Current |
| Smita Kelkar | Director | 14-Nov-1994 | Current |
| Vaibhav Kelkar | Director | 05-Dec-2022 | Current |
Financial Performance of Dr Bais Surgical And Medical Institute.
Dr Bais Surgical And Medical Institute Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 0.39% increase. The company also saw a substantial improvement in profitability, with a 580.36% increase in profit. The company's net worth Soared by an impressive increase of 12.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Bais Surgical And Medical Institute?
In 2017, Dr Bais Surgical And Medical Institute had a promoter holding of 83.60% and a public holding of 16.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.25 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 1.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 1995 | Bank Of Baroda | ₹1.25 Cr | Open |
How Many Employees Work at Dr Bais Surgical And Medical Institute?
Unlock and access historical data on people associated with Dr Bais Surgical And Medical Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Bais Surgical And Medical Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Bais Surgical And Medical Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.